ClearPoint Neuro Inc CLPT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
ClearPoint Neuro Reports Third Quarter 2026 Results
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
Trading Information
- Previous Close Price
- $7.31
- Day Range
- $6.85–7.45
- 52-Week Range
- $6.85–19.63
- Bid/Ask
- $6.91 / $8.65
- Shares Outstanding
- 32.05M
- Market Cap
- $221.49M
- Volume/Avg
- 1M / 695,479
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.54
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 172
Valuation
Metric | CLPT |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.12 |
Price/Sales | 4.54 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | CLPT |
|---|---|
Quick Ratio | 5.49 |
Current Ratio | 6.76 |
Interest Coverage | −6.04 |
Quick Ratio
CLPT
Profitability
Metric | CLPT |
|---|---|
Return on Assets (Normalized) | −30.81% |
Return on Equity (Normalized) | −137.89% |
Return on Invested Capital (Normalized) | −30.03% |
Return on Assets
CLPT
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|z<%?mL | LOCK|!@<C? | $178B | |||
| Medtronic PLC MDT | LOCK|^Y%N!q | LOCK|jmkC? | $128B | |||
| Stryker Corp SYK | LOCK|kL%Q#wy | LOCK|b& | $118B | |||
| Boston Scientific Corp BSX | LOCK|$@xhs! | LOCK|rTy# | $61B | |||
| Edwards Lifesciences Corp EW | LOCK|XhL$v^t | LOCK|RC>< | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|By?pq? | LOCK|?K | $36B | |||
| DexCom Inc DXCM | LOCK|#&n%$@V | LOCK|WJp&h | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|<FM | LOCK|fTX | $28B | |||
| Steris PLC STE | LOCK|!Sn@F! | LOCK|lVt#w | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|LDfJ&xYH | LOCK|Gq# | $19B |